• Je něco špatně v tomto záznamu ?

Review about Structure and Evaluation of Reactivators of Acetylcholinesterase Inhibited with Neurotoxic Organophosphorus Compounds

JD. Figueroa-Villar, EC. Petronilho, K. Kuca, TCC. Franca

. 2021 ; 28 (7) : 1422-1442. [pub] -

Jazyk angličtina Země Spojené arabské emiráty

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc21019508

BACKGROUND: Neurotoxic chemical warfare agents can be classified as some of the most dangerous chemicals for humanity. The most effective of those agents are the Organophosphates (OPs) capable of restricting the enzyme Acetylcholinesterase (AChE), which in turn, controls the nerve impulse transmission. When AChE is inhibited by OPs, its reactivation can be usually performed through cationic oximes. However, until today, it has not been developed one universal defense agent, with complete effective reactivation activity for AChE inhibited by any of the many types of existing neurotoxic OPs. For this reason, before treating people intoxicated by an OP, it is necessary to determine the neurotoxic compound that was used for contamination, in order to select the most effective oxime. Unfortunately, this task usually requires a relatively long time, raising the possibility of death. Cationic oximes also display a limited capacity of permeating the Blood-Brain Barrier (BBB). This fact compromises their capacity to reactivating AChE inside the nervous system. METHODS: We performed a comprehensive search on the data about OPs available on the scientific literature today in order to cover all the main drawbacks still faced in the research for the development of effective antidotes against those compounds. RESULTS: Therefore, this review about neurotoxic OPs and the reactivation of AChE, provides insights for the new agents' development. The most expected defense agent is a molecule without toxicity and effective to reactivate AChE inhibited by all neurotoxic OPs. CONCLUSION: To develop these new agents, the application of diverse scientific areas of research, especially theoretical procedures as computational science (computer simulation, docking and dynamics), organic synthesis, spectroscopic methodologies, biology, biochemical and biophysical information, medicinal chemistry, pharmacology and toxicology, is necessary.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21019508
003      
CZ-PrNML
005      
20210830101105.0
007      
ta
008      
210728s2021 ts f 000 0|eng||
009      
AR
024    7_
$a 10.2174/0929867327666200425213215 $2 doi
035    __
$a (PubMed)32334495
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ts
100    1_
$a Figueroa-Villar, José Daniel $u Medicinal Chemistry Group, Department of Chemical Engineering, Military Institute of Engineering, 22270- 090, Rio de Janeiro, Brazil
245    10
$a Review about Structure and Evaluation of Reactivators of Acetylcholinesterase Inhibited with Neurotoxic Organophosphorus Compounds / $c JD. Figueroa-Villar, EC. Petronilho, K. Kuca, TCC. Franca
520    9_
$a BACKGROUND: Neurotoxic chemical warfare agents can be classified as some of the most dangerous chemicals for humanity. The most effective of those agents are the Organophosphates (OPs) capable of restricting the enzyme Acetylcholinesterase (AChE), which in turn, controls the nerve impulse transmission. When AChE is inhibited by OPs, its reactivation can be usually performed through cationic oximes. However, until today, it has not been developed one universal defense agent, with complete effective reactivation activity for AChE inhibited by any of the many types of existing neurotoxic OPs. For this reason, before treating people intoxicated by an OP, it is necessary to determine the neurotoxic compound that was used for contamination, in order to select the most effective oxime. Unfortunately, this task usually requires a relatively long time, raising the possibility of death. Cationic oximes also display a limited capacity of permeating the Blood-Brain Barrier (BBB). This fact compromises their capacity to reactivating AChE inside the nervous system. METHODS: We performed a comprehensive search on the data about OPs available on the scientific literature today in order to cover all the main drawbacks still faced in the research for the development of effective antidotes against those compounds. RESULTS: Therefore, this review about neurotoxic OPs and the reactivation of AChE, provides insights for the new agents' development. The most expected defense agent is a molecule without toxicity and effective to reactivate AChE inhibited by all neurotoxic OPs. CONCLUSION: To develop these new agents, the application of diverse scientific areas of research, especially theoretical procedures as computational science (computer simulation, docking and dynamics), organic synthesis, spectroscopic methodologies, biology, biochemical and biophysical information, medicinal chemistry, pharmacology and toxicology, is necessary.
650    12
$a acetylcholinesterasa $7 D000110
650    _2
$a cholinesterasové inhibitory $x toxicita $7 D002800
650    12
$a reaktivátory cholinesterasy $x farmakologie $7 D002801
650    _2
$a počítačová simulace $7 D003198
650    _2
$a lidé $7 D006801
650    _2
$a organofosforové sloučeniny $x toxicita $7 D009943
650    _2
$a oximy $x farmakologie $7 D010091
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Petronilho, Elaine C $u Medicinal Chemistry Group, Department of Chemical Engineering, Military Institute of Engineering, 22270- 090, Rio de Janeiro, Brazil
700    1_
$a Kuca, Kamil $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Králové 50003, Czech Republic
700    1_
$a Franca, Tanos C C $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Králové 50003, Czech Republic
773    0_
$w MED00001274 $t Current medicinal chemistry $x 1875-533X $g Roč. 28, č. 7 (2021), s. 1422-1442
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32334495 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20210830101105 $b ABA008
999    __
$a ok $b bmc $g 1690354 $s 1139954
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 28 $c 7 $d 1422-1442 $e - $i 1875-533X $m Current medicinal chemistry $n Curr Med Chem $x MED00001274
LZP    __
$a Pubmed-20210728

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...